Rx Rundown: AbbVie, Purdue Pharma, HHS and more
Check out this week’s medical marketing news, dealmaking and industry chatter. Deals AbbVie and Neomorph announced a collaboration worth up to $1.64 billion to develop molecular glue degraders for oncology and immunology. Kantar Group announced the $1 …